125 related articles for article (PubMed ID: 5068347)
21. [Blood-aqueous barrier changes during activation of fibrinolysis in plasma].
Rudobielski R
Klin Oczna; 1974 Feb; 44(2):129-33. PubMed ID: 4453093
[No Abstract] [Full Text] [Related]
22. [Clinical studies on the effectiveness of Xantinol-nicotinate in chronic hepatitis and liver cirrhosis].
Dohrmann RE; Konrad D; Sawade H; Kühl I
Med Klin; 1968 Nov; 63(44):1772-6. PubMed ID: 5704508
[No Abstract] [Full Text] [Related]
23. [Comparative study on the modification of oxygen consumption of rat liver and brain homogenates by xanthinol nicotinate and nicotinic acid].
Brenner G
Arzneimittelforschung; 1974 Mar; 24(3):321-5. PubMed ID: 4407877
[No Abstract] [Full Text] [Related]
24. [Influence of xanthinol nicotinate on hyperlactacidemia induced by epinephrine and norepinephrine].
Brenner G
Arzneimittelforschung; 1970 Dec; 20(12):1860-2. PubMed ID: 5537081
[No Abstract] [Full Text] [Related]
25. [Acute effect of xanthinol nicotinate on cutaneous and intramuscular temperature in diabetic patients].
Berezovsky MR; Berstein S; Lopez Morillas AM; Novoa FC; Acuña E; Reitich GE; Gottlieb S
Prensa Med Argent; 1971 Jul; 58(18):923-31. PubMed ID: 5095397
[No Abstract] [Full Text] [Related]
26. [Therapy of hyperlipemia using xantinol-nicotinate].
Möller-Hardenack B
Med Monatsschr; 1973 Aug; 27(8):370-2. PubMed ID: 4756297
[No Abstract] [Full Text] [Related]
27. [Fibrinolysis by nicotinic acid derivatives].
Thies HA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):216-9. PubMed ID: 4106011
[No Abstract] [Full Text] [Related]
28. [Effects of xanthinol nicotinate on the irrigation of the musculature of the limbs and of the skin].
Klüken N; Schmidt H
Angiologia; 1972; 24(6):271-80. PubMed ID: 4641643
[No Abstract] [Full Text] [Related]
29. [Thrombolytic action of the tissue activator profibrinolysin and nicotinic acid].
Andreenko GV; Migalina LA
Vopr Med Khim; 1973; 19(4):371-4. PubMed ID: 4788286
[No Abstract] [Full Text] [Related]
30. [Changes in serum electrolytes, serum proteins and substances, normally contained in the urine during therapy of feto-placentar insufficiency using xantinol nicotinate and heparin].
Kidess E; Bieling C; Kunz S; Liebich HM
Med Welt; 1973 Dec; 24(51):2029-32. PubMed ID: 4774572
[No Abstract] [Full Text] [Related]
31. [Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. I. Cardiocirculatory effects in normal subjects].
De Gregorio G; Arcoraci A; Arrigo F
Cardiol Prat; 1971 Aug; 22(4):271-80. PubMed ID: 5136159
[No Abstract] [Full Text] [Related]
32. [Elucidation of the mechanism of nicotinic acid flush in the animal experiment (author's transl)].
Rohte O; Thormählen D; Ochlich P
Arzneimittelforschung; 1977; 27(12):2347-52. PubMed ID: 23799
[TBL] [Abstract][Full Text] [Related]
33. [Effect of heparin on fibrinolysis, complement, and kinin generation systems (author's transl)].
Nakagawa M; Kitani T
Rinsho Ketsueki; 1981 Jul; 22(7):1016-22. PubMed ID: 7328761
[No Abstract] [Full Text] [Related]
34. [Studies on the effect of xantinol-nicotinate on heart and blood circulation].
Lang E; Köhler JA
Arzneimittelforschung; 1969 Nov; 19(11):1870-3. PubMed ID: 5395658
[No Abstract] [Full Text] [Related]
35. [Clinical and experimental studies on fibrinolysis activation].
Bielawiec M
Rocz Akad Med Im Juliana Marchlewskiego Bialymst Suppl; 1967; 15():1-92. PubMed ID: 4953138
[No Abstract] [Full Text] [Related]
36. [Effects of complamin on the coagulation system of mature and premature newborn infants].
Maak B; Dämlow U; Frenzel J
Monatsschr Kinderheilkd (1902); 1971 Sep; 119(9):502-5. PubMed ID: 5097243
[No Abstract] [Full Text] [Related]
37. [Modification of the vascular changes of the ocular fundus by xantinol nicotinate].
von Grósz I; Födö V
Med Welt; 1969 Aug; 35():1916-7. PubMed ID: 5809867
[No Abstract] [Full Text] [Related]
38. [Nicotinic acid and fibrinolysis in humans. I. Regional fibrinolysis (cerebral, of the upper extremity and of the lower extremity) caused by "arterial" administration of nicotinic acid].
Tesi M
Riv Crit Clin Med; 1967 Dec; 67(6):465-83. PubMed ID: 5603691
[No Abstract] [Full Text] [Related]
39. Fibrinogen turnover in the aged subjects following the administration of drugs acting on fibrinolysis.
De Nicola P; Cultrera G; Manai G
Farmaco Sci; 1968 Oct; 23(10):994-8. PubMed ID: 5712798
[No Abstract] [Full Text] [Related]
40. Studies on fibrinolytic activity in normal persons and patients with atherosclerotic vascular disease after physical activity and injections of nicotinic acid.
Laursen B; Gormsen J
Angiology; 1970 Jul; 21(7):486-92. PubMed ID: 4988093
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
